Payment will be provided when TTVR is delivered for an FDA-approved indication in the context of a CMS-approved study.

CMS has approved Medicare and Medicaid coverage for transcatheter tricuspid valve replacement procedures for the treatment of ...

In this randomized controlled trial, a transcatheter tricuspid-valve replacement provided a mortality benefit compared to ...

Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the ...

US medical device company Laplace Interventional has completed a Series C financing round to support the completion of an early feasibility study (EFS) of its transcatheter tricuspid valve (TTV) ...

A groundbreaking heart procedure at MedStar Union Memorial Hospital has made Maryland history. Joan Mertz, 83, became the first patient in the state to undergo an artificial heart valve replacement ...

In a groundbreaking event for Arizona healthcare, HonorHealth Scottsdale Shea Medical Center recently became the first ...

Cardiogenic shock remains a challenging clinical syndrome characterized by critically impaired cardiac output, systemic hypoperfusion, and high mortality ...

Laplace Interventional announced today that it completed a Series C financing round to support its prosthetic heart valve technology.

A first of its kind surgery to help people with a specific type of heart failure is going through clinical trials at Providence St. Vincent’s.

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

The funding will be put towards an early feasibility study, designed to determine the clinical effectiveness and safety of Laplace’s transcatheter tricuspid valve replacement system. If ...